Veterinary Neurodegenerative Disease Diagnostics Market Size, Share, Trends, & Industry Analysis Report By Product (Consumables, Reagents, & Kits and Equipment & Instruments), By Test, By Animal Type, By Indication, By End Use, and By Region – Market Fore
Description
The veterinary neurodegenerative disease diagnostics market size is expected to reach USD 805.79 million by 2034, according to a new study by Polaris Market Research. The report “Veterinary Neurodegenerative Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report By Product (Consumables, Reagents & Kits and Equipment & Instruments), By Test, By Animal Type, By Indication, By End Use, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The veterinary neurodegenerative disease diagnostics is a specialized sector within the broader veterinary healthcare industry, focusing on the detection and management of neurodegenerative disorders in animals. Neurodegenerative diseases such as cognitive dysfunction syndrome (CDS) in dogs, feline dementia, and equine motor neuron disease are increasingly recognized as serious health concerns in aging pets and livestock. Early and accurate diagnosis is crucial for managing these conditions, improving animal welfare, and extending quality of life.
The market encompasses various diagnostic tools, including advanced imaging techniques, cerebrospinal fluid (CSF) analysis, gene therapy, and biomarker assessments. The growing awareness of neurological disorders in animals, coupled with advancements in veterinary diagnostics, is driving market expansion. Additionally, the rising trend of pet humanization, where pets are considered family members, is leading to increased spending on advanced veterinary care, further propelling demand for neurodegenerative disease diagnostics.
Veterinary Neurodegenerative Disease Diagnostics Market Report Highlights
In terms of product, the consumables, reagents & kits segment accounted for a major share in 2024 due to their essential role in early detection and accurate diagnosis of neurological disorders in animals.
Based on test, the imaging segment dominated the market share in 2024 due to its critical role in identifying abnormalities in the brain and spinal cord of animals.
In terms of animal type, the companion segment held the largest share in 2024, owing to the rising prevalence of neurological disorders in aging pets, particularly dogs and cats.
The North America veterinary neurodegenerative disease diagnostics market accounted for the largest share in 2024 due to the rising prevalence of neurodegenerative disorders in pets, particularly in dog and cat populations.
The market in Europe is projected to grow at a robust pace in the coming years, owing to the increasing geriatric pet population and growing awareness of neurological disorders.
The market in Asia Pacific is projected to hold a substantial share in 2034 due to rising pet adoption, increasing disposable income, and improving veterinary healthcare infrastructure.
A few global key market players include ACUVET BIOTECH; Antech Diagnostics, Inc.; Avacta Animal Health Limited; Heska Corporation; IDEXX Laboratories, Inc.; Life Diagnostics; Merck & Co., Inc.; Mercodia AB; MI:RNA Diagnostics Ltd.; Virbac; and Zoetis.
Polaris Market Research has segmented the veterinary neurodegenerative disease diagnostics market report on the basis of product, test, animal type, indication, end use, and region:
By Product Outlook (Revenue, USD Million, 2020–2034)
Consumables, Reagents & Kits
Equipment & Instruments
By Test Outlook (Revenue, USD Million, 2020–2034)
Imaging
MRI (Magnetic Resonance Imaging)
CT (Computed Tomography)
Others
Biomarker Diagnostic Tests
CSF (Cerebrospinal Fluid) biomarkers
Blood-based biomarkers
Others
Others
By Animal Type Outlook (Revenue, USD Million, 2020–2034)
Livestock
Sheep
Cattle
Others
Companion
Canine
Feline
Equine
Others
By Indication Outlook (Revenue, USD Million, 2020–2034)
Cognitive Dysfunction
Cerebellar Abiotrophy
Spongiform Encephalopathies
Others
By End Use Outlook (Revenue, USD Million, 2020–2034
Veterinary Hospitals and Clinics
Veterinary Diagnostic Laboratories
Others
By Regional Outlook (Revenue, USD Million, 2020–2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
The veterinary neurodegenerative disease diagnostics is a specialized sector within the broader veterinary healthcare industry, focusing on the detection and management of neurodegenerative disorders in animals. Neurodegenerative diseases such as cognitive dysfunction syndrome (CDS) in dogs, feline dementia, and equine motor neuron disease are increasingly recognized as serious health concerns in aging pets and livestock. Early and accurate diagnosis is crucial for managing these conditions, improving animal welfare, and extending quality of life.
The market encompasses various diagnostic tools, including advanced imaging techniques, cerebrospinal fluid (CSF) analysis, gene therapy, and biomarker assessments. The growing awareness of neurological disorders in animals, coupled with advancements in veterinary diagnostics, is driving market expansion. Additionally, the rising trend of pet humanization, where pets are considered family members, is leading to increased spending on advanced veterinary care, further propelling demand for neurodegenerative disease diagnostics.
Veterinary Neurodegenerative Disease Diagnostics Market Report Highlights
In terms of product, the consumables, reagents & kits segment accounted for a major share in 2024 due to their essential role in early detection and accurate diagnosis of neurological disorders in animals.
Based on test, the imaging segment dominated the market share in 2024 due to its critical role in identifying abnormalities in the brain and spinal cord of animals.
In terms of animal type, the companion segment held the largest share in 2024, owing to the rising prevalence of neurological disorders in aging pets, particularly dogs and cats.
The North America veterinary neurodegenerative disease diagnostics market accounted for the largest share in 2024 due to the rising prevalence of neurodegenerative disorders in pets, particularly in dog and cat populations.
The market in Europe is projected to grow at a robust pace in the coming years, owing to the increasing geriatric pet population and growing awareness of neurological disorders.
The market in Asia Pacific is projected to hold a substantial share in 2034 due to rising pet adoption, increasing disposable income, and improving veterinary healthcare infrastructure.
A few global key market players include ACUVET BIOTECH; Antech Diagnostics, Inc.; Avacta Animal Health Limited; Heska Corporation; IDEXX Laboratories, Inc.; Life Diagnostics; Merck & Co., Inc.; Mercodia AB; MI:RNA Diagnostics Ltd.; Virbac; and Zoetis.
Polaris Market Research has segmented the veterinary neurodegenerative disease diagnostics market report on the basis of product, test, animal type, indication, end use, and region:
By Product Outlook (Revenue, USD Million, 2020–2034)
Consumables, Reagents & Kits
Equipment & Instruments
By Test Outlook (Revenue, USD Million, 2020–2034)
Imaging
MRI (Magnetic Resonance Imaging)
CT (Computed Tomography)
Others
Biomarker Diagnostic Tests
CSF (Cerebrospinal Fluid) biomarkers
Blood-based biomarkers
Others
Others
By Animal Type Outlook (Revenue, USD Million, 2020–2034)
Livestock
Sheep
Cattle
Others
Companion
Canine
Feline
Equine
Others
By Indication Outlook (Revenue, USD Million, 2020–2034)
Cognitive Dysfunction
Cerebellar Abiotrophy
Spongiform Encephalopathies
Others
By End Use Outlook (Revenue, USD Million, 2020–2034
Veterinary Hospitals and Clinics
Veterinary Diagnostic Laboratories
Others
By Regional Outlook (Revenue, USD Million, 2020–2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
129 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
- 4. Global Veterinary Artificial Insemination Market Insights
- 4.1. Veterinary Artificial Insemination Market – Market Snapshot
- 4.2. Veterinary Artificial Insemination Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increased Demand for Superior Genetic Traits in Animals
- 4.2.1.2. Minimizing Risks Associated with Animal Breeding
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Lack of skilled professionals
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Veterinary Artificial Insemination Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Veterinary Artificial Insemination Market, by Solution
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 5.3. Equipment & Consumables
- 5.3.1. Global Veterinary Artificial Insemination Market, by Equipment & Consumables, by Region, 2020–2034 (USD Billion)
- 5.4. Semen
- 5.4.1. Global Veterinary Artificial Insemination Market, by Semen, by Region, 2020–2034 (USD Billion)
- 5.5. Services
- 5.5.1. Global Veterinary Artificial Insemination Market, by Services, by Region, 2020–2034 (USD Billion)
- 6. Global Veterinary Artificial Insemination Market, by Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 6.3. Bovine
- 6.3.1. Global Veterinary Artificial Insemination Market, by Bovine, by Region, 2020–2034 (USD Billion)
- 6.4. Swine
- 6.4.1. Global Veterinary Artificial Insemination Market, by Swine, by Region, 2020–2034 (USD Billion)
- 6.5. Ovine & Caprine
- 6.5.1. Global Veterinary Artificial Insemination Market, by Ovine & Caprine, by Region, 2020–2034 (USD Billion)
- 6.6. Equine
- 6.6.1. Global Veterinary Artificial Insemination Market, by Equine, by Region, 2020–2034 (USD Billion)
- 6.7. Others
- 6.7.1. Global Veterinary Artificial Insemination Market, by Others, by Region, 2020–2034 (USD Billion)
- 7. Global Veterinary Artificial Insemination Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 7.3. Private
- 7.3.1. Global Veterinary Artificial Insemination Market, by Private, by Region, 2020–2034 (USD Billion)
- 7.4. Public
- 7.4.1. Global Veterinary Artificial Insemination Market, by Public, by Region, 2020–2034 (USD Billion)
- 8. Global Veterinary Artificial Insemination Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Veterinary Artificial Insemination Market Assessment, By Geography, 2020–2034 (USD Billion)
- 8.3. Veterinary Artificial Insemination Market – North America
- 8.3.1. North America: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.3.2. North America: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.3.3. North America: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.3.4. Veterinary Artificial Insemination Market – U.S.
- 8.3.4.1. U.S.: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.3.4.2. U.S.: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.3.4.3. U.S.: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.3.5. Veterinary Artificial Insemination Market – Canada
- 8.3.5.1. Canada: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.3.5.2. Canada: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.3.5.3. Canada: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.4. Veterinary Artificial Insemination Market – Europe
- 8.4.1. Europe: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.4.2. Europe: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.4.3. Europe: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.4.4. Veterinary Artificial Insemination Market – UK
- 8.4.4.1. UK: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.4.4.2. UK: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.4.4.3. UK: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.4.5. Veterinary Artificial Insemination Market – France
- 8.4.5.1. France: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.4.5.2. France: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.4.5.3. France: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.4.6. Veterinary Artificial Insemination Market – Germany
- 8.4.6.1. Germany: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.4.6.2. Germany: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.4.6.3. Germany: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.4.7. Veterinary Artificial Insemination Market – Italy
- 8.4.7.1. Italy: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.4.7.2. Italy: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.4.7.3. Italy: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.4.8. Veterinary Artificial Insemination Market – Spain
- 8.4.8.1. Spain: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.4.8.2. Spain: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.4.8.3. Spain: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.4.9. Veterinary Artificial Insemination Market – Netherlands
- 8.4.9.1. Netherlands: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.4.9.2. Netherlands: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.4.9.3. Netherlands: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.4.10. Veterinary Artificial Insemination Market – Russia
- 8.4.10.1. Russia: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.4.10.2. Russia: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.4.10.3. Russia: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.4.11. Veterinary Artificial Insemination Market – Rest of Europe
- 8.4.11.1. Rest of Europe: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.5. Veterinary Artificial Insemination Market – Asia Pacific
- 8.5.1. Asia Pacific: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.5.2. Asia Pacific: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.5.3. Asia Pacific: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.5.4. Veterinary Artificial Insemination Market – China
- 8.5.4.1. China: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.5.4.2. China: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.5.4.3. China: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.5.5. Veterinary Artificial Insemination Market – India
- 8.5.5.1. India: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.5.5.2. India: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.5.5.3. India: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.5.6. Veterinary Artificial Insemination Market – Malaysia
- 8.5.6.1. Malaysia: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.5.6.2. Malaysia: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.5.6.3. Malaysia: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.5.7. Veterinary Artificial Insemination Market – Japan
- 8.5.7.1. Japan: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.5.7.2. Japan: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.5.7.3. Japan: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.5.8. Veterinary Artificial Insemination Market – Indonesia
- 8.5.8.1. Indonesia: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.5.8.2. Indonesia: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.5.8.3. Indonesia: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.5.9. Veterinary Artificial Insemination Market – South Korea
- 8.5.9.1. South Korea: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.5.9.2. South Korea: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.5.9.3. South Korea: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.5.10. Veterinary Artificial Insemination Market – Australia
- 8.5.10.1. Australia: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.5.10.2. Australia: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.5.10.3. Australia: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.5.11. Veterinary Artificial Insemination Market – Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.6. Veterinary Artificial Insemination Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.6.2. Middle East & Africa: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.6.3. Middle East & Africa: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.6.4. Veterinary Artificial Insemination Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.6.5. Veterinary Artificial Insemination Market – UAE
- 8.6.5.1. UAE: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.6.5.2. UAE: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.6.5.3. UAE: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.6.6. Veterinary Artificial Insemination Market – Israel
- 8.6.6.1. Israel: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.6.6.2. Israel: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.6.6.3. Israel: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.6.7. Veterinary Artificial Insemination Market – South Africa
- 8.6.7.1. South Africa: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.6.7.2. South Africa: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.6.7.3. South Africa: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.6.8. Veterinary Artificial Insemination Market – Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.7. Veterinary Artificial Insemination Market – Latin America
- 8.7.1. Latin America: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.7.2. Latin America: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.7.3. Latin America: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.7.4. Veterinary Artificial Insemination Market – Mexico
- 8.7.4.1. Mexico: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.7.4.2. Mexico: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.7.4.3. Mexico: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.7.5. Veterinary Artificial Insemination Market – Brazil
- 8.7.5.1. Brazil: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.7.5.2. Brazil: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.7.5.3. Brazil: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.7.6. Veterinary Artificial Insemination Market – Argentina
- 8.7.6.1. Argentina: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.7.6.2. Argentina: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.7.6.3. Argentina: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 8.7.7. Veterinary Artificial Insemination Market – Rest of Latin America
- 8.7.7.1. Rest of Latin America: Veterinary Artificial Insemination Market, by Solution, 2020–2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Veterinary Artificial Insemination Market, by Type, 2020–2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Veterinary Artificial Insemination Market, by Distribution Channel, 2020–2034 (USD Billion)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. CRV
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Genus plc (ABS Global)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. IMV Technologies
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Neogen Corporation
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Select Sires Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. STgenetics
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Swine Genetics International, Ltd.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. URUS Group LP
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Viking Genetics
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Zoetis Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
